These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26121536)

  • 1. How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society.
    Gladstone DJ; Geerts WH; Douketis J; Ivers N; Healey JS; Leblanc K
    Ann Intern Med; 2015 Sep; 163(5):382-5. PubMed ID: 26121536
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.
    Zoppellaro G; Granziera S; Padayattil Jose S; Denas G; Bracco A; Iliceto S; Pengo V
    Expert Opin Drug Saf; 2015 May; 14(5):683-95. PubMed ID: 25803739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalizing oral anticoagulant treatment in patients with atrial fibrillation.
    Capranzano P; Miccichè E; D'Urso L; Privitera F; Tamburino C
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):959-73. PubMed ID: 23957907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic treatment in atrial fibrillation.
    Kalra L; Lip GY;
    Heart; 2007 Jan; 93(1):39-44. PubMed ID: 16952971
    [No Abstract]   [Full Text] [Related]  

  • 6. MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.
    Flaker G
    Trends Cardiovasc Med; 2016 Apr; 26(3):292. PubMed ID: 26874917
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
    Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
    Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin in non-valvular atrial fibrillation.
    Dalby AJ; Wessels P; Opie LH
    S Afr Med J; 2013 Oct; 103(12):901-4. PubMed ID: 24300625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. My Approach to the use of NOACs for stroke prevention in patients with atrial fibrillation.
    Lip GY
    Trends Cardiovasc Med; 2014 Aug; 24(6):265-6. PubMed ID: 25106085
    [No Abstract]   [Full Text] [Related]  

  • 11. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
    Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
    Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-specific oral anticoagulants for stroke prevention in patients with atrial fibrillation: real-world considerations.
    Rosenberg DJ; Ansell J
    Hosp Pract (1995); 2012 Aug; 40(3):50-7. PubMed ID: 23086094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of stroke in nonvalvular atrial fibrillation. Oral direct factor Xa inhibitor apixaban: positive experiences in general medical practice].
    MMW Fortschr Med; 2013 Sep; 155(16):62-3. PubMed ID: 24279159
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulation for atrial fibrillation: state of the art and recommendations for a quickly moving target.
    Nattel S; Cairns J; Healey JS; Talajic M
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S1-3. PubMed ID: 23790593
    [No Abstract]   [Full Text] [Related]  

  • 17. North American Thrombosis Forum, AF Action Initiative Consensus Document.
    Ruff CT; Ansell JE; Becker RC; Benjamin EJ; Deicicchi DJ; Mark Estes NA; Ezekowitz MD; Fanikos J; Fareed J; Garcia D; Giugliano RP; Goldhaber SZ; Granger C; Healey JS; Hull R; Hylek EM; Libby P; Lopes RD; Mahaffey KW; Mega J; Piazza G; Sasahara AA; Sorond FA; Spyropoulos AC; Walenga JM; Weitz JI
    Am J Med; 2016 May; 129(5 Suppl):S1-S29. PubMed ID: 27126598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oral anticoagulants for stroke prevention in the geriatric population.
    Kim D; Barna R; Bridgeman MB; Brunetti L
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):15-29. PubMed ID: 24234513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.